Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
July 17, 2024 16:14 ET
|
NurExone Biologic Inc
TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
June 28, 2024 16:04 ET
|
NurExone Biologic Inc
Prestigious Eye Institute Exploring New Indication for NurExone’s ExoPTEN
Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 Billion Opportunity by 2034 with Regional and Country-Level Data for Types, Drugs, Treatments, and End-users
March 12, 2024 12:13 ET
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region" report has been added to ...
Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to Reach USD 9.1 billion by 2031 | Transparency Market Research, Inc.
December 19, 2023 03:41 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The glaucoma treatment market was valued at US$ 6.3 billion in 2022. A CAGR of 4.3% is...
Ocular Hypertension Pipeline Research Report 2023: Comprehensive Insights About 70+ Companies and 75+ Pipeline Drugs
November 24, 2023 05:43 ET
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "Ocular Hypertension - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ocular Hypertension - Pipeline...
Prostaglandin Analogs Dominating Global Glaucoma Treatment Market - Ongoing Technological Advancements Boost Growth
August 03, 2023 07:48 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Glaucoma Treatment Market by Indication, Type, Sales Channel - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering. ...
Glaucoma Treatment Market Report (2023 to 2031) – Alcon, Merck & Co., Inc., Novartis AG, Pfizer Inc., and AbbVie Inc.
June 13, 2023 09:30 ET
|
Growth Plus Reports
Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glaucoma treatment market was conducted by Growth Plus Reports in 2022 and is valued at US$ 5.89 billion....
Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
September 20, 2022 05:18 ET
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
Global Glaucoma Markets and Competitive Landscape Report 2021-2026
September 10, 2021 03:33 ET
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Glaucoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Global Glaucoma Market and...
Europe Glaucoma Market and Competitive Landscape Report 2021-2026
September 10, 2021 02:58 ET
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Glaucoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe Glaucoma Market and...